Significance of Wnt signaling in pleural mesothelioma
Project/Area Number |
19590910
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Saitama Medical University |
Principal Investigator |
UEMATSU Kazutsugu Saitama Medical University, 医学部, 准教授 (10297880)
|
Co-Investigator(Kenkyū-buntansha) |
森山 岳 埼玉医科大学, 医学部, 助教 (30364798)
|
Co-Investigator(Renkei-kenkyūsha) |
MORIYAMA Gaku 埼玉医科大学, 医学部, 助教 (30364798)
|
Project Period (FY) |
2007 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2007: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 胸膜中皮腫 / WNTシグナル / Dishevelled(Dvl) / 中皮腫 / Wntシグナル / Dvl / Dv1 |
Research Abstract |
To clarify the effect of blocking Wnt signaling in mesothelioma, we down-regulated the expression of dishevelled (Dvl), an intermediator of Wnt signaling, by a small interfering RNA (siRNA). Mesothelioma cell lines were transfected with siRNA of Dvl, and cell growth was examined. The synergistic effect on cell growth of Dvl siRNA and cisplatin in combination was evaluated. Dvl siRNA down-regulated the expression of Dvl in mesothelioma cells, which caused suppression of cell growth. Combination of Dvl siRNA and cisplatin suppressed cell growth synergistically. Our data suggest that inhibition of Wnt signaling leads to significant anti-tumor effects.
|
Report
(4 results)
Research Products
(16 results)
-
[Journal Article] Frequency of and variables associated with the EGFR mutation and its subtypes.2010
Author(s)
Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, Nagai Y, Moriyama G, Miyazawa H, Ikebuchi K, Morita S, Kobayashi K, Hagiwara K.
-
Journal Title
International Journal of Cancer 126
Pages: 651-655
Related Report
Peer Reviewed
-
[Journal Article] Frequency of and variables associated with the EGFR mutation and its subtypes2010
Author(s)
Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, Nagai Y, Moriyama G, Miyazawa H, Ikebuchi K, Morita S, Kobayashi K, Hagiwara K.
-
Journal Title
International Journal of Cancer 126
Pages: 651-655
Related Report
Peer Reviewed
-
[Journal Article] Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis.2009
Author(s)
Takenaka T, Gemma A, Yoshimura A, Hosoya Y, Nara M, Hosomi Y, Okano T, Kunugi S, Koizumi K, Fukuda Y, Uematsu K, Shimizu K, Kudoh S.
-
Journal Title
Molecular Medicine Reports Vol.2
Pages: 73-80
Related Report
Peer Reviewed
-
[Journal Article] Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis2009
Author(s)
Takenaka T, Gemma A Yoshimura A, Hosoya Y, Nara M, Hosomi Y, Okano T, Kunugi S, Koizumi K, Fukuda Y, Uematsu K, Shimizu K, Kudoh S.
-
Journal Title
Molecular Medicine Reports 2
Pages: 73-80
Related Report
Peer Reviewed
-
-
[Journal Article] Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.2008
Author(s)
Seto T, Yamanaka T, Nakano M, Ota M, Maruyama R, Okamoto T, Wataya H, Uematsu K, Seki N, Eguchi K, Semba H, Ichinose Y.
-
Journal Title
Journal of Thoracic Oncology Vol.3
Pages: 637-642
Related Report
Peer Reviewed
-
[Journal Article] Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.2008
Author(s)
Seto T, Yamanaka T, Nakano M, Ota M, Maruyama R, Okamoto T, Wataya H, Uematsu K, Seki N, Eguchi K, Semba H, Iehinose Y.
-
Journal Title
Journal of Thoracic Oncology 3
Pages: 637-642
Related Report
Peer Reviewed
-
-
[Journal Article] Targeting the Wnt Signaling Pathway with Dishevelled and Cisplatin Synergistically Suppresses Mesothelioma Cell Growth.2007
Author(s)
Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K.
-
Journal Title
Anticancer Research Vol.27
Pages: 4239-4242
Related Report
-
-
[Journal Article] Targeting the Wnt Signaling Pathway with Dishevelled and Cisplatin Synergistically Suppresses Mesothelioma Cell Growth2007
Author(s)
Uematsu K., Seki N., Seto T., Isoe C., Tsukamoto H., Mikami I., You L., He B., Xu Z., Jablons D.M., Eguchi K.
-
Journal Title
Anticancer Research 27
Pages: 4239-4242
Related Report
Peer Reviewed
-
-
[Presentation] 当院における若年者肺癌臨床的検討.2008
Author(s)
森山岳, 山本和男, 山名一平, 大岩健満, 杣知行, 植松和嗣, 小林国彦, 弦間昭彦, 工藤翔二
Organizer
第48回日本呼吸器学会総会
Place of Presentation
神戸
Year and Date
2008-06-15
Related Report
-
[Presentation] 当院における若年者肺癌臨床的検討2008
Author(s)
森山岳, 山本和男, 山名一平, 大岩健満, 杣知行, 植松和嗣, 小林国彦, 弦間昭彦, 工藤翔二
Organizer
第48回日本呼吸器学会総会
Place of Presentation
神戸
Year and Date
2008-06-15
Related Report
-
-